RC
VIVS

RegentAtlantic Capital’s VivoSim Labs VIVS Stock Holding History

RegentAtlantic Capital’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10
Closed -$16.7K – 989
2014
Q4 		$16.7K Buy
+10
New +$15.4K ﹤0.01% 796

Other funds holding VIVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RegentAtlantic Capital's VIVS Position: Q1 2015 in Review

RegentAtlantic Capital sold out of VivoSim Labs (VIVS) in Q1 2015, closing a stake of 10 shares — an estimated $16.7K sold.

RegentAtlantic Capital first reported a position in VIVS in Q4 2014 and held it in 1 quarter. The position peaked at $16.7K in Q4 2014. 104 funds tracked by Wall St. Rank hold VIVS as of Q1 2015.

  • RegentAtlantic Capital reported no remaining VivoSim Labs position as of Q1 2015 after selling out during the quarter.
  • RegentAtlantic Capital sold 10 VivoSim Labs shares in Q1 2015, an estimated $16.7K.
  • RegentAtlantic Capital first reported a position in VivoSim Labs in Q4 2014 and held it in 1 quarter.
  • RegentAtlantic Capital's VivoSim Labs position peaked at $16.7K in Q4 2014.
  • 104 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2015.

Based on RegentAtlantic Capital's 13F filing for Q1 2015, filed 27 Apr 2015.